Dailiport Hart forðahylki 2 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

dailiport hart forðahylki 2 mg

sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg

Dailiport Hart forðahylki 3 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

dailiport hart forðahylki 3 mg

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg

Erlotinib WH Filmuhúðuð tafla 150 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

erlotinib wh filmuhúðuð tafla 150 mg

williams & halls ehf. - erlotinibum hýdróklóríð - filmuhúðuð tafla - 150 mg

Orfiril Magasýruþolin tafla 150 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril magasýruþolin tafla 150 mg

desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 150 mg

Orfiril Magasýruþolin tafla 600 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril magasýruþolin tafla 600 mg

desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 600 mg

Orfiril Mixtúra, lausn 60 mg/ml Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril mixtúra, lausn 60 mg/ml

desitin arzneimittel gmbh - natrii valproas - mixtúra, lausn - 60 mg/ml

Orfiril Retard Forðatafla 300 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril retard forðatafla 300 mg

desitin arzneimittel gmbh - natrii valproas - forðatafla - 300 mg

Orgovyx Europska Unija - islandski - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - blöðruhálskirtli - innkirtla meðferð - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.